Phibro Animal Health (PAHC) Tops Q3 EPS by 10c ; Offers Guidance

Phibro Animal Health (NASDAQ: PAHC) reported Q3 EPS of $0.63, $0.10 better than the analyst estimate of $0.53. Revenue for the quarter came in at $347.8 million versus the consensus estimate of $309.5 million.

GUIDANCE:

Phibro Animal Health sees FY2025 EPS of $1.96-$2.09, versus the consensus of $1.94. Phibro Animal Health sees FY2025 revenue of $1.26-1.29 billion, versus the consensus of $1.28 billion.

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.

You May Also Be Interested In

• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• Bernstein SocGen Group Reiterates Outperform Rating on UnitedHealth Group (UNH)
• Momentic Launches the First Agentic Quality Platform as AI Continues to Scale Code Output